Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18724778 | METHOD AND SYSTEM FOR DETECTING A CONNECTION TERMINAL | June 2024 | May 2025 | Allow | 11 | 0 | 0 | Yes | No |
| 17112337 | ACOUSTIC MONITORING FOR ELECTROSURGERY | December 2020 | August 2024 | Abandon | 44 | 2 | 1 | No | No |
| 17016290 | MOBILE, WEARABLE EEG DEVICE WITH HIGH QUALITY SENSORS | September 2020 | November 2024 | Abandon | 50 | 1 | 1 | No | No |
| 16865204 | MEDICAL ABLATION DEVICE AND METHOD OF USE | May 2020 | December 2023 | Abandon | 43 | 1 | 0 | No | No |
| 16055014 | METHOD AND APPARATUS FOR TREATMENT OF HYPERTENSION THROUGH PERCUTANEOUS ULTRASOUND RENAL DENERVATION | August 2018 | July 2021 | Allow | 35 | 1 | 0 | Yes | No |
| 15940629 | COMPUTER IMPLEMENTED INTERACTIVE SURGICAL SYSTEMS | March 2018 | December 2024 | Abandon | 60 | 7 | 0 | No | No |
| 15898486 | ULTRASOUND POSITIONING DEVICE, SYSTEM, AND METHOD | February 2018 | September 2021 | Allow | 43 | 2 | 1 | Yes | No |
| 15811520 | METHODS AND SYSTEMS FOR REAL-TIME PLANNING AND MONITORING OF ABLATION NEEDLE DEPLOYMENT IN TISSUE | November 2017 | September 2021 | Allow | 46 | 2 | 1 | No | No |
| 15569686 | IMPROVEMENTS RELATED TO ULTRASOUND IMAGING OF THE FOOT | October 2017 | October 2021 | Allow | 47 | 2 | 0 | Yes | No |
| 15607842 | IN VIVO DETECTION OF A XENON-BINDING CAGE MOLECULE | May 2017 | September 2021 | Allow | 52 | 4 | 0 | No | No |
| 15187397 | TRANSCRANIAL DOPPLER PROBE | June 2016 | August 2021 | Allow | 60 | 2 | 1 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner RODDEN, JOANNE M works in Art Unit 3794 and has examined 10 patent applications in our dataset. With an allowance rate of 60.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 47 months.
Examiner RODDEN, JOANNE M's allowance rate of 60.0% places them in the 20% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by RODDEN, JOANNE M receive 2.40 office actions before reaching final disposition. This places the examiner in the 69% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by RODDEN, JOANNE M is 47 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +66.7% benefit to allowance rate for applications examined by RODDEN, JOANNE M. This interview benefit is in the 98% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 23.1% of applications are subsequently allowed. This success rate is in the 31% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 75.0% of cases where such amendments are filed. This entry rate is in the 94% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.